Fomepizole (Addition) -- Adults and Children
Drug information
Section 4: Antidotes and other substances used in poisonings
Formulation:
Application prepared by:
Guangduo Zhang, Kasumi Crews, Heather Wiseman, Nicola Bates, Medical Toxicology Information Services Ltd., London, UK
Knut Erik Hovda, The National NBC Center, Department of Acute Medicine, Oslo University Hospital Ullevaal, Oslo, Norway
John RH Archer, Paul I Dargan, Clinical Toxicology, Guy’s and St Thomas’ NHS Foundation Trust and King’s Health Partners, London, UK
-
Application to Include Fomepizole on the WHO Model List of Essential Medicines
pdf, 1.61Mb - EXPERT REVIEWS
-
Comments from Dr J. Tempowski, Evidence and Policy on Environmental Health Issues
pdf, 73kb -
Comments from Dr K. McMartin, Department of Pharmacology, Toxicology & Neuroscience, LSU Health Sciences Center
pdf, 83kb -
Comments from Dr Hans Persson, Former Director of the Swedish Poisons Information Centre
pdf, 68kb -
Letter of support from Dr T. Peredy
pdf, 80kb